Literature DB >> 8125217

Dose-dependent disposition of sodium arsenate in mice following acute oral exposure.

M F Hughes1, M Menache, D J Thompson.   

Abstract

The effect of dose on arsenate disposition was studied in adult female B6C3F1 mice, dosed po with 0.5 to 5000 micrograms/kg [73As]-arsenate in water. Urine was collected at 1, 2, 4, 8, 12, 24, and 48 hr and feces at 24 and 48 hr postexposure. The mice were euthanized at 48 hr and tissues were removed. Recovery of arsenate-derived radioactivity ranged from 83 to 89%; 66-79% of the dose was excreted in urine, 10-18% in feces, and < 1% remained in the tissues. Although dose had no effect on the 48-hr excretion of radioactivity, the level of radioactivity in several tissues increased significantly with dose. The urine was analyzed for arsenic metabolites by using ion chromatography to analyze for arsenate, methylarsonic acid (MMA), and dimethylarsinic acid (DMA); ion-pairing high-performance liquid chromatography was used for arsenite analysis. Arsenate elimination ranged from 3 to 15%. DMA was the predominant metabolite excreted (51-64% of dose), but no effect of dose on its elimination was detected. As the dose of arsenate increased, the amount of MMA excreted (0.1-1.0% of dose) significantly increased. At 5000 micrograms/kg arsenate, a significant increase in arsenite excretion was observed. At doses of arsenate < or = 500 micrograms/kg, peak elimination of DMA occurred within 4 hr postexposure. At the 5000 micrograms/kg dose, DMA peak elimination shifted to 8 hr and a lower amount was excreted. In addition, at the 5000 micrograms/kg dose, there was an increase of arsenate and arsenite in the 1- and 2-hr urines. These results suggest that an acute dose of arsenate can affect the metabolism of arsenicals. High doses lead to the accumulation of intermediates that are more reactive than DMA, and this response may lead to increased toxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125217     DOI: 10.1006/faat.1994.1011

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  10 in total

1.  Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite.

Authors:  Vicenta Devesa; Blakely M Adair; Jie Liu; Michael P Waalkes; Bhalchandra A Diwan; Miroslav Styblo; David J Thomas
Journal:  Toxicology       Date:  2006-05-03       Impact factor: 4.221

2.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

3.  Relative bioavailability and bioaccessibility and speciation of arsenic in contaminated soils.

Authors:  Karen D Bradham; Kirk G Scheckel; Clay M Nelson; Paul E Seales; Grace E Lee; Michael F Hughes; Bradley W Miller; Aaron Yeow; Thomas Gilmore; Sophia M Serda; Sharon Harper; David J Thomas
Journal:  Environ Health Perspect       Date:  2011-07-13       Impact factor: 9.031

4.  Airborne arsenic and urinary excretion of arsenic metabolites during boiler cleaning operations in a Slovak coal-fired power plant.

Authors:  J W Yager; J B Hicks; E Fabianova
Journal:  Environ Health Perspect       Date:  1997-08       Impact factor: 9.031

5.  Issues in arsenic cancer risk assessment.

Authors:  T M Slayton; B D Beck; K A Reynolds; S D Chapnick; P A Valberg; L J Yost; R A Schoof; T D Gauthier; L Jones
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

6.  Intercomparison of analytical methods for arsenic speciation in human urine.

Authors:  E Crecelius; J Yager
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 7.  The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence.

Authors:  Chin-Chi Kuo; Katherine A Moon; Shu-Li Wang; Ellen Silbergeld; Ana Navas-Acien
Journal:  Environ Health Perspect       Date:  2017-08-01       Impact factor: 9.031

8.  Arsenite exposure suppresses adipogenesis, mitochondrial biogenesis and thermogenesis via autophagy inhibition in brown adipose tissue.

Authors:  Jiyoung Bae; Yura Jang; Heejeong Kim; Kalika Mahato; Cameron Schaecher; Isaac M Kim; Eunju Kim; Seung-Hyun Ro
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

Review 9.  Arsenic Exposure and Risk of Urothelial Cancer: Systematic Review and Meta-Analysis.

Authors:  Pamela Di Giovanni; Giuseppe Di Martino; Piera Scampoli; Fabrizio Cedrone; Francesca Meo; Giuseppe Lucisano; Ferdinando Romano; Tommaso Staniscia
Journal:  Int J Environ Res Public Health       Date:  2020-04-29       Impact factor: 3.390

10.  Risk and revisionism in arsenic cancer risk assessment.

Authors:  P Mushak; A F Crocetti
Journal:  Environ Health Perspect       Date:  1995 Jul-Aug       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.